Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockage - Mascelli, MA; Lance, ET; Damaraju, L (Circulation, 1998)
et al.